Anthony Matteo, MD
Gynecology · Horsham, PANPI 1063636694
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 27.3% of the total. Reporting peaked in 2022 at $444 and has fallen 74.5% since, to $113 in 2025.
Across 80 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$402
- Therapeuticsmd, Inc.$287
- Mayne Pharma Commercial LLC$174
- Coopersurgical, Inc.$107
- Avion Pharmaceuticals$98
- Millicent US Inc$72
- plus $333 from 10 others
What the payments were for
- Food & beverage$1,472100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $402 |
| Therapeuticsmd, Inc. | 16 | $287 |
| Mayne Pharma Commercial LLC | 9 | $174 |
| Coopersurgical, Inc. | 7 | $107 |
| Avion Pharmaceuticals | 6 | $98 |
| Millicent US Inc | 4 | $72 |
| Myovant Sciences Inc. | 4 | $70 |
| Boston Scientific | 4 | $53 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Astellas Pharma US Inc | 2 | $39 |
| Urovant Sciences Inc | 1 | $34 |
| Merck | 1 | $22 |
| Amgen | 1 | $21 |
| Electromed, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Dysis Medical, Inc. | 1 | $17 |
How this compares
$1,472 in reported general payments places this provider in the 65th percentile of 98 gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 11 | $4,632 |
| Famciclovir | 12 | $89 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Horsham
- Denise RanucciHorsham$2K
- Jordan KlebanoffNewtown Square$187K
- Harry ReichShavertown$136K
- Gretchen MakaiYork$102K
- Karen TangBryn Mawr$96K
- Joseph TalvacchiaPhiladelphia$85K
- David ToubWyncote$41K
- David EvansCarlisle$30K
- Harold DavisScranton$22K
- Reneita RossPhiladelphia$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.